Exacerbations in patients with severe asthma who are being treated with mepolizumab can be categorised into two distinct types, UK researchers have reported. The results suggest that a more precision medicine approach may be useful in treating acute wheezing episodes in this group of patients. Data from a study at four specialist severe asthma centres ...
Two distinct types of asthma exacerbation in patients on mepolizumab
By Emma Wilkinson
20 May 2021